review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1026341832 |
P356 | DOI | 10.1007/S11906-001-0082-Y |
P698 | PubMed publication ID | 11177710 |
P50 | author | ??? | Q38591102 |
P2093 | author name string | Luft FC | |
P2860 | cites work | Does superoxide underlie the pathogenesis of hypertension? | Q24560022 |
AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation | Q28139447 | ||
Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress | Q28372941 | ||
Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases | Q29547555 | ||
Cellular survival: a play in three Akts | Q29547806 | ||
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 | ||
New insights into the interaction of Ras with the plasma membrane | Q33691054 | ||
State-of-the-Art lecture. Statins and blockers of the renin-angiotensin system: vascular protection beyond their primary mode of action | Q33752650 | ||
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway | Q33903180 | ||
A family of constitutive C/EBP-like DNA binding proteins attenuate the IL-1 alpha induced, NF kappa B mediated trans-activation of the angiotensinogen gene acute-phase response element | Q33923274 | ||
Oxidant signaling in vascular cell growth, death, and survival : a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. | Q33991556 | ||
Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants | Q34033893 | ||
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline | Q37351830 | ||
Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator | Q38359909 | ||
Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective | Q40584311 | ||
Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy | Q40870045 | ||
Endotoxin-induced renal inflammatory response. Oncostatin M as a major mediator of suppressed renin expression | Q40880558 | ||
Activate NF-kappa B or die? | Q41397219 | ||
Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells | Q42493329 | ||
ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis | Q42796771 | ||
Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. | Q47909651 | ||
High plasma level of N-acetyl-seryl-aspartyl-lysyl-proline: a new marker of chronic angiotensin-converting enzyme inhibition. | Q50924399 | ||
High human renin hypertension in transgenic rats. | Q53003369 | ||
Blood pressure-independent effects in rats with human renin and angiotensinogen genes. | Q54062419 | ||
The hemoregulatory peptide N-acetyl-ser-asp-lys-pro impairs angiotensin I-induced contractions in rat aorta | Q60621588 | ||
NADH/NADPH Oxidase and Vascular Function | Q63365800 | ||
Transcription factors modulating angiotensinogen gene expression in hepatocytes | Q72118285 | ||
Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells | Q73087569 | ||
Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells | Q73176746 | ||
Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis | Q73182905 | ||
Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men | Q73205391 | ||
Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis | Q73267274 | ||
Angiotensin II induces nuclear factor (NF)-kappaB1 isoforms to bind the angiotensinogen gene acute-phase response element: a stimulus-specific pathway for NF-kappaB activation | Q73340504 | ||
NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats | Q73371618 | ||
Angiotensin-converting enzyme expression in human carotid artery atherosclerosis | Q73371662 | ||
Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes | Q73371663 | ||
Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability | Q73590707 | ||
Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species | Q73675626 | ||
Rapid communication. Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction | Q73783872 | ||
Angiotensin III increases MCP-1 and activates NF-kappaB and AP-1 in cultured mesangial and mononuclear cells | Q73873417 | ||
Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms | Q73919597 | ||
Increased activity of nuclear factor-kappaB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats | Q74172837 | ||
Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage | Q74188173 | ||
Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway | Q74316935 | ||
CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension | Q74316940 | ||
Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors | Q77215422 | ||
Effects of HMG-CoA reductase inhibition on PDGF- and angiotensin II- mediated signal transduction: suppression of c-Jun and c-Fos in human smooth muscle cells in vitro | Q77330812 | ||
Angiotensin II signal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases | Q77804609 | ||
Hypertension-induced end-organ damage : A new transgenic approach to an old problem | Q77945584 | ||
Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension | Q77945688 | ||
Angiotensin induces inflammatory activation of human vascular smooth muscle cells | Q77974630 | ||
Angiotensin II (ATII)-inducible platelet-derived growth factor A-chain gene expression is p42/44 extracellular signal-regulated kinase-1/2 and Egr-1-dependent and mediated via the ATII type 1 but not type 2 receptor. Induction by ATII antagonized by | Q78122180 | ||
P433 | issue | 1 | |
P921 | main subject | arterial hypertension | Q41861 |
cardiovascular disease | Q389735 | ||
inflammation | Q101991 | ||
P304 | page(s) | 61-67 | |
P577 | publication date | 2001-02-01 | |
P1433 | published in | Current Hypertension Reports | Q15746362 |
P1476 | title | Angiotensin, inflammation, hypertension, and cardiovascular disease | |
P478 | volume | 3 |